Corrigendum: The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis

other OA: gold CC-BY-4.0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This corrigendum corrects the article DOI for a paper that investigated the potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This paper is a corrigendum to a previously published article examining the potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis. The authors correct an error in the original funding statement by adding the required U.S. EPA disclaimer and correcting the EPA grant information from an incomplete listing (“R839501”) to the full assistance agreement number (RD83950101). They state that the funding-statement correction does not change the scientific conclusions, and that the original article has been updated. This paper is centrally about endometriosis and adenomyosis — it specifically addresses funding/disclaimer corrections for a study focused on how environmental endocrine disruptors may relate to these conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

[This corrects the article DOI: 10.3389/fphys.2021.807685.].
Full text 3,459 characters · extracted from oa-doi-fallback · click to expand
In the published article, there was an error in the Funding statement. The authors omitted the disclaimer, which is required by the U.S. EPA, from their Funding statement. The EPA grant number was also incomplete and was listed as “R839501.” “This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM007628 (JR), Training Program in Environmental Toxicology under award number TOX T32 ES007028 (VS), Bill and Melinda Gates Foundation (KB-T and KO), and U.S. Environmental Protection Agency #R839501 (KB-T and KO), R01HD096147 (KB-T and KO).” The correct Funding statement appears below. “The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis” was developed under Assistance Agreement No. RD83950101 awarded by the U.S. Environmental Protection Agency to KO. It has not been formally reviewed by EPA. The views expressed in this document are solely those of VS, JR, SA, KB-T, and KO and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.” The authors apologize for this errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Statements Publisher’s note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Author disclaimer The views expressed in this document are solely those of VS, JR, SA, KB-T, and KO and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication. Summary Keywords endometriosis, adenomyosis, environmental toxicants, endocrine disrupting chemical (EDC), inflammation Citation Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL and Osteen KG (2023) Corrigendum: The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis. Front. Physiol. 14:1260961. doi: 10.3389/fphys.2023.1260961 Received 18 July 2023 Accepted 08 August 2023 Published 14 August 2023 Approved by Frontiers Editorial Office, Frontiers Media SA, Switzerland Volume 14 - 2023 Updates Copyright © 2023 Stephens, Rumph, Ameli, Bruner-Tran and Osteen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Kevin G. Osteen, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-14T06:17:53.580500+00:00
pubmed
last seen: 2026-09-14T06:16:40.897692+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine